A major discovery in cancer study is emerging with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in many types of malignancies, leading https://socialicus.com/story7472351/mini-antibodies-revive-the-p53-protein-the-potential-pathway-for-tumor-treatment